ConductScience.org, home

Paper36976323

Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.

Yashar WM and 14 others. Mol Cancer Res, 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Papers, record 36976323. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36976323

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.
PubMed
Journal
Mol Cancer Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2024-05-11
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
fms-Like Tyrosine Kinase 3Major topic
Leukemia, Myeloid, AcuteMajor topic
Humans
Apoptosis
Histone Demethylases
Mutation
Protein Kinase Inhibitors
STAT5 Transcription Factor

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 GM109835NIGMS NIH HHSUnited StatesT32GM109835PubMed and NIHNIH RePORTER
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
K08 CA245224NCI NIH HHSUnited StatesK08CA245224PubMed and NIHNIH RePORTER
R01 CA247943NCI NIH HHSUnited StatesR01CA247943PubMed and NIHNIH RePORTER
U54 CA224019NCI NIH HHSUnited StatesU54CA224019PubMed and NIHNIH RePORTER
R01 CA065823NCI NIH HHSUnited StatesR01CA065823PubMed and NIHNIH RePORTER
R01 CA282133NCI NIH HHSUnited StatesR01CA282133PubMedNIH RePORTER
P30 CA069533NCI NIH HHSUnited StatesP30CA069533PubMedNIH RePORTER

Download CSV of grants

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133148262The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer.Mol Cancer2020https://conductscience.org/library/papers/33148262PubMed
29694804PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.Genes Dev1998https://conductscience.org/library/papers/9694804PubMed
315620353Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.Cell2004https://conductscience.org/library/papers/15620353PubMed
425982114BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.Mol Cell2015https://conductscience.org/library/papers/25982114PubMed
529706549Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation.Cell2018https://conductscience.org/library/papers/29706549PubMed
630333627Functional genomic landscape of acute myeloid leukaemia.Nature2018https://conductscience.org/library/papers/30333627PubMed
730420889The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease.Stem Cells Int2018https://conductscience.org/library/papers/30420889PubMed
836259537Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation.Elife2022https://conductscience.org/library/papers/36259537PubMed
917277777Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.Nat Genet2007https://conductscience.org/library/papers/17277777PubMed
1025684206A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.Mol Cell2015https://conductscience.org/library/papers/25684206PubMed
1131036827CUT&Tag for efficient epigenomic profiling of small samples and single cells.Nat Commun2019https://conductscience.org/library/papers/31036827PubMed
1216885027Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.Mol Cell2006https://conductscience.org/library/papers/16885027PubMed
1335590033PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.Leukemia2022https://conductscience.org/library/papers/35590033PubMed
1417686054Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells.Br J Haematol2007https://conductscience.org/library/papers/17686054PubMed
1528079019An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites.Elife2017https://conductscience.org/library/papers/28079019PubMed
1629590629Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia.Cell Rep2018https://conductscience.org/library/papers/29590629PubMed
1721106759Histone H3K27ac separates active from poised enhancers and predicts developmental state.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/21106759PubMed
1820434979Regulation of RNA polymerase II elongation by c-Myc.Cell2010https://conductscience.org/library/papers/20434979PubMed
1929453291LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML.Blood2018https://conductscience.org/library/papers/29453291PubMed
2028159741Biology and relevance of human acute myeloid leukemia stem cells.Blood2017https://conductscience.org/library/papers/28159741PubMed

See all 53 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42139346P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML.Sci Adv2026https://conductscience.org/library/papers/42139346PubMed
42129910KIT-dependent acute myeloid leukemias are responsive to LSD1 inhibition.Clin Epigenetics2026https://conductscience.org/library/papers/42129910PubMed
41301700Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential.Biomedicines2025https://conductscience.org/library/papers/41301700PubMed
40940894The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence.Cancers (Basel)2025https://conductscience.org/library/papers/40940894PubMed
38455978Predicting transcription factor activity using prior biological information.iScience2024https://conductscience.org/library/papers/38455978PubMed

Download CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADAM238745PubTator's text mininghttps://conductscience.org/library/genes/8745NCBI Gene
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
BRD423476PubTator's text mininghttps://conductscience.org/library/genes/23476NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
CEBPA1050PubTator's text mininghttps://conductscience.org/library/genes/1050NCBI Gene
CST12P106478911PubTator's text mininghttps://conductscience.org/library/genes/106478911NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
G0S250486PubTator's text mininghttps://conductscience.org/library/genes/50486NCBI Gene
GFI12672PubTator's text mininghttps://conductscience.org/library/genes/2672NCBI Gene
GFI1B8328PubTator's text mininghttps://conductscience.org/library/genes/8328NCBI Gene
GUSB2990PubTator's text mininghttps://conductscience.org/library/genes/2990NCBI Gene
IL1RAP3556PubTator's text mininghttps://conductscience.org/library/genes/3556NCBI Gene
IL3RA3563PubTator's text mininghttps://conductscience.org/library/genes/3563NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
KDM1A23028PubTator's text mininghttps://conductscience.org/library/genes/23028NCBI Gene
LYZ4069PubTator's text mininghttps://conductscience.org/library/genes/4069NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36976323

GET https://conductscience.org/api/papers/v1/36976323/references?page=2